Triple Negative Breast Cancer


Keytruda®/Halaven® Combo May Be Effective in Advanced Triple-Negative Breast Cancer (January 9, 2017)

The investigative treatment combination including Keytruda® (pembrolizumab) plus Halaven® (eribulin) could provide a potential therapeutic option for patients with advanced triple-negative breast cancer... Continue Reading

Metastatic Breast Cancer- Ask the Expert, Your Questions Answered (October 11, 2016)

Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD Dr. Dang discussed advances in the management of metastatic breast cancer and answered your questions in a live... Continue Reading

Breast Cancer Awareness Month: Ask Questions, Get Connected (October 1, 2016)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have... Continue Reading

Tecentriq™ Plus Abraxane® Effective Combo in Difficult to Treat Breast Cancer (June 30, 2016)

The combination of the immune stimulating agent Tecentriq™ (atezolizumab), plus the chemotherapy agent Abraxane® (nab-paclitaxel) is effective in providing anti-cancer responses among patients with... Continue Reading

Inspirational Stories From Women With Triple Negative Breast Cancer (June 3, 2016)

Women Magazine is a premier women’s health and wellness magazine covering health and wellness, prevention and treatment topics related to a variety of common women’s health issues, including cancer,... Continue Reading

Strategies to Improve Treatment of TNBC (June 3, 2016)

The development of more effective treatment for TNBC requires that new and innovative therapies be evaluated with cancer patients. Patients may gain access to better treatments by participating in a clinical... Continue Reading

Triple-Negative Breast Cancer (June 3, 2016)

Triple-negative breast cancers (TNBC) lack hormone receptors and the human epidermal growth factor receptor (HER2) meaning that they will not respond to, and cannot be treated with hormone therapy or targeted... Continue Reading

New Breakthrough May Advance Triple Negative Breast Cancer Treatment (May 30, 2016)

By Helen Young Scientists at The Scripps Research Institute have developed a new drug candidate that lowers the growth rate of tumor cells in animal models1 in one of the most difficult cancers to battle:... Continue Reading

Men’s Views of the Women They Love Post-Mastectomy (April 11, 2016)

By John Leifer Despite five decades of effort by feminists, our society continues to bombard women with the message that their femininity and sexual attractiveness are directly tied to their bust-line.... Continue Reading

Complete Pathologic Responses Associated with Prognosis in Triple-Negative Breast Cancer (March 24, 2016)

A complete pathologic response (no cancer cells detected through microscopic evaluation) appears to be the most accurate indicator of long-term prognosis for women with triple-negative breast cancer. These... Continue Reading

Sacituzumab Govitecan Receives Breakthrough Designation for Triple-Negative Breast Cancer (February 23, 2016)

The United States Food and Drug Administration (FDA) has designated the investigative agent, sacituzumab govitecan (IMMU-132), breakthrough designation for the treatment of triple-negative breast cancer. The... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated... Continue Reading

Atezolizumab Plus Abraxane Promising New Treatment for Triple-Negative Breast Cancer (January 7, 2016)

The investigative agent, atezolizumb, in addition to the chemotherapy agent, Abraxane (nab-paclitaxel), provides high anti-cancer responses among patients with triple-negative breast cancer. These results... Continue Reading

Adding Carboplatin to Pre-surgery Chemotherapy Improves Survival for Patients with Triple-Negative Breast Cancer (December 22, 2015)

Adding carboplatin to pre-surgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer (TNBC), according to results from a German clinical study released at the San... Continue Reading

Adding Carboplatin to Pre-surgery Chemotherapy Improves Survival for Patients with Triple-Negative Breast Cancer (December 21, 2015)

Adding carboplatin to pre-surgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer (TNBC), according to results from a German clinical study released at the San... Continue Reading

Precision Medicine (October 6, 2015)

Patients see benefits as cancer care continues to evolve. By Susan Kreimer Donna Lawson, 67, a retired payroll admin­istrator in Glen Rose, Texas, was diagnosed with triple-negative breast cancer—a... Continue Reading

Breast Cancer Research: Have We Made Progress? (January 27, 2015)

Published results from research studies in breast cancer in the last year represent several practice changing milestones. CancerConnect News coverage of advances in the management of breast cancer included... Continue Reading

Young Survivor Profile: Kirby Jamail (December 29, 2014)

Houston, Texas, native Kirby Ja­mail was diagnosed with Stage III, triple-negative breast cancer in August 2013 at age 28. A fitness instructor, Kirby had just moved out on her own at the time and was... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS